Chitotriosidase in the Pathogenesis of Inflammation, Interstitial Lung Diseases and COPD.
- Author:
Soo Jung CHO
1
;
Michael D WEIDEN
;
Chun Geun LEE
Author Information
- Publication Type:Review
- Keywords: Chitotriosidase; sarcoidosis; scleroderma; idiopathic pulmonary fibrosis; inflammation; TGF-beta
- MeSH: Animals; Cell Wall; Chitinase; Fungi; Humans; Idiopathic Pulmonary Fibrosis; Inflammation*; Lung Diseases, Interstitial*; Lung Diseases, Obstructive; Macrophages; Mice; Pulmonary Disease, Chronic Obstructive*; Sarcoidosis; Transforming Growth Factor beta; Transforming Growth Factor beta1
- From:Allergy, Asthma & Immunology Research 2015;7(1):14-21
- CountryRepublic of Korea
- Language:English
- Abstract: As a member of 18 glycosyl hydrolase (GH) family, chitotriosidase (Chitinase 1, CHIT1) is a true chitinase mainly expressed in the differentiated and polarized macrophages. CHIT1 is an innate immune mediator that digests the cell walls of chitin-containing eukaryotic pathogens, such as fungi. However, CHIT1 is dysregulated in granulomatous and fibrotic interstitial lung diseases characterized by inflammation and tissue remodeling. These include tuberclosis, sarcoidosis, idiopathic pulmonary fibrosis, scleroderma-associated interstitial lung diseases (SSc-ILD), and chronic obstructive lung diseases (COPD). CHIT1 serum concentration correlates with the progression or the severity of these diseases, suggesting a potential use of CHIT1 as a biomarker or a therapeutic target. Recent studies with genetically modified mice demonstrate that CHIT1 enhances TGF-beta1 receptor expression and signaling, suggesting a role in initiating or amplifying the response to organ injury and repair. This additional CHIT1 activity is independent of its enzymatic activity. These studies suggest that CHIT1 serves a bridging function; it is both an innate immune mediator and a regulator of tissue remodeling. This review will focus on recent data linking CHIT1 to the pathogenesis of inflammation, interstitial lung disease, and COPD.
